Biotechnology

Techseriesinsight > Blog > News > Biotechnology

April 24, 2025
PRNewswire
Biotechnology

Oncolytics Biotech® to Showcase New Pancreatic Cancer Data at ASCO Highlighting Pelareorep’s Tumor-Fighting Mechanism of Action

Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, will present new data from Cohort 1 of the GOBLET study at the 2025 American Society...

April 24, 2025
PRNewswire
Biotechnology

Bio-Techne Announces Early Access Program for Next-Generation Spatial Protein Proximity Detection

Bio-Techne Corporation (NASDAQ: TECH), a global provider of cutting-edge life science tools, today announced an Early Access Program for its latest advancement in spatial biology: a powerful new assay for...

April 23, 2025
PRNewswire
Biotechnology

Bio-Techne to Showcase Cutting-Edge Solutions at the 2025 American Association for Cancer Research (AACR) Annual Meeting

Bio-Techne Corporation (NASDAQ: TECH) today announced it will showcase its latest advancements in cancer research tools at the 2025 American Association for Cancer Research (AACR) Annual Meeting, taking place April 25-30 at...

April 22, 2025
PRNewswire
Biotechnology

GENE SOLUTIONS AND ELEMENT BIOSCIENCES ENTER STRATEGIC COLLABORATION TO ADVANCE NEXT-GENERATION SEQUENCING (NGS) TECHNOLOGY GLOBALLY

Gene Solutions, a leading multinational biotech company specializing in advanced genetic testing, and Element Biosciences, a company democratizing access to advanced life science solutions, have entered into a strategic collaboration....

April 22, 2025
PRNewswire
Biotechnology

RBL LLC welcomes Devyn Smith to board of directors

RBL LLC, a pioneering biotech venture creation studio dedicated to rapidly building companies based on breakthrough medical technologies from Rice University, announced the appointment of Devyn Smith to its board of directors....

April 17, 2025
PRNewswire
Biotechnology

CytoSorbents Appoints Melanie Grossman, CPA as Vice President and Corporate Controller

CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, today announced the appointment of Melanie Grossman, CPA as...

April 17, 2025
PRNewswire
Biotechnology

Dynavax Files Definitive Proxy Statement and Sends Letter to Stockholders

Dynavax Technologies Corporation (Nasdaq: DVAX) (“Dynavax” or the “Company”), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, today announced that it has filed definitive proxy materials with the Securities and Exchange...

April 16, 2025
PRNewswire
Biotechnology

28 CAPITAL LAUNCHES NEW VENTURE TO ADVANCE SCIENTIFIC BREAKTHROUGHS FOR PATIENTS

28 Capital, a next-generation life sciences venture capital firm co-founded by biotech entrepreneur John Boyce and venture capitalist Audrey Warner, today announced the launch of its newest platform. Focused on translating cutting-edge...

April 16, 2025
PRNewswire
Biotechnology

An Open Letter to Shareholders of TransCode Therapeutics, Inc. Asking Stockholders to Vote FOR the Proposal to Authorize a Reverse Stock Split if Necessary

TransCode Therapeutics, Inc. today released an open letter to stockholders regarding the upcoming special meeting to be held April 21. Stockholders are asked to approve a Reverse Split should...

April 15, 2025
PRNewswire
Biotechnology

ThirtyFiveBio Closes Bridge Round of Financing Highlighted by Strategic New Investment from AbbVie Ventures

ThirtyFiveBio Limited, a biotechnology company developing first-in-class small molecule inhibitors of G protein-coupled receptor 35 (GPR35) for the treatment of gastrointestinal (GI) disease, today announced the closing of a...